Login to Your Account



Funding Aplenty Now

Algeta's Alpharadin Bayer Deal: $800M Fixes Thorium Headache

By Catherine Hollingsworth


Friday, September 4, 2009
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription